Literature DB >> 26854247

Iron-induced oxidative stress activates AKT and ERK1/2 and decreases Dyrk1B and PRMT1 in neuroblastoma SH-SY5Y cells.

Elizabeth Bautista1, Paula Vergara1, José Segovia2.   

Abstract

Iron is essential for proper neuronal functioning; however, excessive accumulation of brain iron is reported in Parkinson's, Alzheimer's, Huntington's diseases and amyotrophic lateral sclerosis. This indicates that dysregulated iron homeostasis is involved in the pathogenesis of these diseases. To determinate the effect of iron on oxidative stress and on cell survival pathways, such as AKT, ERK1/2 and DyrK1B, neuroblastoma SH-SY5Y cells were exposed to different concentration of FeCl2 (iron). We found that iron induced cell death in SH-SY5Y cells in a concentration-dependent manner. Detection of iNOS and 3-nitrotyrosine confirms the presence of increased nitrogen species. Furthermore, we found a decrease of catalase and protein arginine methyl-transferase 1 (PRMT1). Interestingly, iron increased the activity of ERK and AKT and reduced DyrK1B. Moreover, after FeCl2 treatment, the transcription factors c-Jun and pSmad1/5 were activated. These results indicate that the presence of high levels of iron increase the vulnerability of neurons to oxidative stress.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  AKT; DyrK1B; ERK1/2; Iron; Oxidative stress; PRMT1; Smad; c-jun

Mesh:

Substances:

Year:  2015        PMID: 26854247     DOI: 10.1016/j.jtemb.2015.11.005

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  11 in total

Review 1.  Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.

Authors:  Paul J Derry; Muralidhar L Hegde; George R Jackson; Rakez Kayed; James M Tour; Ah-Lim Tsai; Thomas A Kent
Journal:  Prog Neurobiol       Date:  2019-10-08       Impact factor: 11.685

2.  Dexmedetomidine Promotes SH-SY5Y Cell Resistance Against Impairment of Iron Overload by Inhibiting NF-κB Pathways.

Authors:  Xi-Bei Hu; Zhi-Yu Xi; Lin-Qing Liu; Kai Kang; Wan-Hong Li; Yu-Xian Shen; Fang Kang; Juan Li
Journal:  Neurochem Res       Date:  2019-01-29       Impact factor: 3.996

Review 3.  The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer's Disease: An Overview and Update on New Developments.

Authors:  Mohammad Rafi Khezri; Keyvan Yousefi; Ayda Esmaeili; Morteza Ghasemnejad-Berenji
Journal:  Cell Mol Neurobiol       Date:  2022-01-17       Impact factor: 5.046

Review 4.  Therapeutic strategies for tauopathies and drug repurposing as a potential approach.

Authors:  Majedul Islam; Fengyun Shen; Deepika Regmi; Deguo Du
Journal:  Biochem Pharmacol       Date:  2022-02-24       Impact factor: 6.100

5.  Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.

Authors:  Shalini S Rao; Larissa Lago; Irene Volitakis; Jay J Shukla; Gawain McColl; David I Finkelstein; Paul A Adlard
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

Review 6.  Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration.

Authors:  Shalini S Rao; Paul Anthony Adlard
Journal:  Front Mol Neurosci       Date:  2018-08-17       Impact factor: 5.639

7.  Protection of Iron-Induced Oxidative Damage in Neuroblastoma (SH-SY5Y) Cells by Combination of 1-(N-Acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one and Green Tea Extract.

Authors:  Nittaya Chansiw; Kanokwan Kulprachakarn; Narisara Paradee; Adchara Prommaban; Somdet Srichairatanakool
Journal:  Bioinorg Chem Appl       Date:  2021-04-20       Impact factor: 7.778

8.  Anti-influenza A virus activity of rhein through regulating oxidative stress, TLR4, Akt, MAPK, and NF-κB signal pathways.

Authors:  Qian-Wen Wang; Yun Su; Jiang-Tao Sheng; Li-Ming Gu; Ying Zhao; Xiao-Xuan Chen; Cheng Chen; Wei-Zhong Li; Kang-Sheng Li; Jian-Ping Dai
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

9.  Effect of α2‑macroglobulin in the early stage of jaw osteoradionecrosis.

Authors:  Jie Li; Ping Yin; Xueying Chen; Xiangbo Kong; Wanzhen Zhong; Yaping Ge; Yangyang She; Xuehong Xian; Lei Qi; Zhi Lin; Justine Moe; Silian Fang
Journal:  Int J Oncol       Date:  2020-04-23       Impact factor: 5.650

10.  Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells.

Authors:  Mathilde Foisy-Sauvé; Lena Ahmarani; Edgard Delvin; Alain T Sané; Schohraya Spahis; Emile Levy
Journal:  Nutrients       Date:  2020-04-22       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.